Consumer groups ask FTC to block Novo Holdings-Catalent deal
U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, ...
Novo Nordisk A/S (NVO): Most Promising Future Stock According to Analysts
We recently compiled a list of the 10 Most Promising Future Stocks According to Analysts. In this article, we are going to ...
Jim Cramer Says Novo Nordisk A/S (NVO) ‘Doesn’t Hold A Candle To Eli Lilly’
We recently published an article titled, Jim Cramer’s Latest Lightning Round: 12 Stocks to Watch. In this article, we are ...
Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Futurism on MSN1d
Ozempic Could Be Used to Treat Alcohol and Drug Addiction, Study Finds
In a huge new statistical analysis, researchers have found more evidence than ever that drugs like Ozempic can help curb ...
3 No-Brainer Growth Stocks to Buy in October
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
How Eli Lilly Outpaces Nvidia—Here Is One Chart
Despite this, investors seem to have made up their one-track mind. Eli Lilly’s P/E ratio is more than double that of Novo ...
FiercePharma16h
EU drug reviewers back Novo Nordisk’s FDA-rejected hemophilia drug, snub PTC’s Translarna again
After hitting a wall with the FDA last year, Novo Nordisk has picked up backing from European drug reviewers for its novel ...
Behind the Scenes of Novo Nordisk's Latest Options Trends
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
Novo Nordisk: CHMP Recommends Approval Of Alhemo - Quick Facts
Novo Nordisk announced the European Medicines Agency's CHMP has adopted a positive opinion, recommending approval of Alhemo as the ...
After US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of Catalent
Public interest groups are urging the FTC to block Novo Holdings' $16.5 billion acquisition of Catalent, citing concerns over ...
Novo Nordisk A/S (NYSE:NVO) Shares Down 0.4% on Analyst Downgrade
Novo Nordisk A/S (NYSE:NVO – Get Free Report)’s share price fell 0.4% during mid-day trading on Friday after BMO Capital Markets lowered their price target on the stock from $160.00 to $156.00. BMO ...